Member Info for TrickyEFC

Recal

An event that is spinning or has already spun out of control with disatrous results

They may have painted a good picture months back but the vibes they giving off ain't good vibrations.

Several grand that I would of liked to invest in GPL could be down the swanny.

Could be, game is still in play.

If by any chance the telegram group was legit (cringe) the tool should be booted for speaking and acting in such an unprofessional manner.

Telegram for fook sake

Said it before mms ain't got much to play with here and have work to fill orders.

Freefloat under 50% and in Very sticky hands.

On the bank of a banging RNS

16-Dec-24 08:25:33 0.24 10,200,000 Unknown* 24.48k real money comes in.

Your right. I appreciate your greater understanding of it.

Inregards to the asic no idea like everyone else.

Yes and the further north of 0.1p means less of a hit to enet.

That was the one point I was making.

They are currently 32% above that price and currently New tech have no shares. So we understand the $170k. Hopefully more money for the final TSP payment.

But enet are 32% above the 0.1p

£170,000 (however, this amount may vary depending on the relevant exercise price at the time of exercise). Were the relevant exercise price to be higher than 0.1p, then the outstanding balance would be lower than £170,000, For example, were the relevant exercise price to be 0.3p then the outstanding balance would be £90,000.

It's a fantastic deal and to be honest fair play for the awakn holders having a premium of 110% paid.

Long term we stand to gain a lot more from the deal than they do.

Great interview.

Hopefully now the market will wake up as it's been spoon fed the details.

This is currently cheap as chips.

As for finishing down we did so on the day of university results.

Hopefully they have flushed the sellers out and we move up again over coming days.

The euro fins result is the big one for now.

👀

MDMA/Zydis Program

Goal:

Develop MDMA into an Oral Disintegrating Tablet (ODT) for pre-gastric absorption to address known pharmacokinetic challenges with MDMA in oral tablet format.

Status:

Awakn has executed an exclusive development agreement with Catalent, a global leader in drug formulation. Agreement focuses on developing and testing a market-ready proprietary formulation and optimized delivery route for MDMA using Catalent’s proprietary Zydis® platform orally disintegrating tablet (ODT) technology.

https://awaknlifesciences.com/mdma

And this. OFT ties in lovely with gpl .

About AWKN-002

AWKN-002 is a novel psychedelic MAT consisting of a patent pending proprietary esketamine oral thin film (OTF), administered sub-lingually and buccally in combination with manualized psycho-social support to treat AUD in the US.

Status:

Awakn has in-licensed a successfully completed Ph1 program with patents filed international and with global exclusivity for addiction, anxiety, and eating disorders

Goals:

Target an FDA 505(b)(2) pathway

Progress AWKN-002 to late clinical stage and seek commercial opportunities

IP:

S-ketamine OTF patents filed in US, China, Canada, Europe, and Japan

We get this 😁

AWKN-001

AWKN-001 is a novel medication-assisted treatment for severe Alcohol Use Disorder, consisting of an N-methyl-D-aspartate receptor-modulating drug (ketamine) delivered intravenously (IV) in combination with manualized psycho-social support for severe alcohol use disorder in the UK market only.

AWKN-001 is in phase 3 planning. The phase 3 trial (“More Kare”) will be run by the University of Exeter and is co-funded by the UK National Institute for Health Research (NIHR) Efficacy and Mechanism Evaluation Programme (NIHR150193) and Awakn.

AWKN-001 phase 2 was successful completed with efficacy proven, achieving on 86% abstinence on average over the 6 months post treatment versus 2% pre-trial and a 50% reduction in heavy drinking days versus placebo.

Phase 3 enrolment is due to start in Q3 2024

In consideration for the Initial Payment, the Company shall be entitled to 40% of the future net income generated by Awakn's aminoindane NCE programme ("Participating Interest")

We get 100% of any future income now from nce but we also get the AUD which is at a more advanced stage.

Hopefully Dennis has some more news for us shortly.

I would like to think that the holders over there where in it with a view to the long game.

Wonder what gpl will be trading at come 6 months.

They seemed to be well liked as an investment.

https://www.marketscreener.com/quote/stock/AWAKN-LIFE-SCIENCES-CORP-124600187/news/Awakn-Life-Sciences-Announces-Upsizing-and-Closing-of-Tranche-of-Private-Placement-Financing-47891843/

Https://www.stocktitan.net/news/AWKNF/awakn-life-sciences-enters-into-binding-letter-of-intent-for-lmaerhok7ypu.html

Coming back stronger than a powered up pacman

Should move on up now.

It's good news.